Cancer and leukemia group b/southwest oncology group trial 80405

A phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma

Alan P. Venook, Charles Blanke, Donna Niedzwiecki, Heinz Josef Lenz, John R. Taylor, Donna R. Hollis, Susan Sutherland, Richard M. Goldberg

Research output: Contribution to journalArticle

25 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)292-294
Number of pages3
JournalClinical Colorectal Cancer
Volume5
Issue number4
DOIs
StatePublished - 2005

Fingerprint

Organoplatinum Compounds
Antineoplastic Combined Chemotherapy Protocols
Camptothecin
Leucovorin
Neoplasm Staging
Biological Products
Fluorouracil
Antineoplastic Agents
Colorectal Neoplasms
Leukemia
Adenocarcinoma
Monoclonal Antibodies
Drug Therapy
Neoplasms
Bevacizumab
Cetuximab

Keywords

  • Bevacizumab
  • Cetuximab
  • FOLFIRI
  • FOLFOX

ASJC Scopus subject areas

  • Oncology

Cite this

Cancer and leukemia group b/southwest oncology group trial 80405 : A phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma. / Venook, Alan P.; Blanke, Charles; Niedzwiecki, Donna; Lenz, Heinz Josef; Taylor, John R.; Hollis, Donna R.; Sutherland, Susan; Goldberg, Richard M.

In: Clinical Colorectal Cancer, Vol. 5, No. 4, 2005, p. 292-294.

Research output: Contribution to journalArticle

Venook, Alan P. ; Blanke, Charles ; Niedzwiecki, Donna ; Lenz, Heinz Josef ; Taylor, John R. ; Hollis, Donna R. ; Sutherland, Susan ; Goldberg, Richard M. / Cancer and leukemia group b/southwest oncology group trial 80405 : A phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma. In: Clinical Colorectal Cancer. 2005 ; Vol. 5, No. 4. pp. 292-294.
@article{1e0fcead312547e79257cb494251fc2a,
title = "Cancer and leukemia group b/southwest oncology group trial 80405: A phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma",
keywords = "Bevacizumab, Cetuximab, FOLFIRI, FOLFOX",
author = "Venook, {Alan P.} and Charles Blanke and Donna Niedzwiecki and Lenz, {Heinz Josef} and Taylor, {John R.} and Hollis, {Donna R.} and Susan Sutherland and Goldberg, {Richard M.}",
year = "2005",
doi = "10.3816/CCC.2005.n.043",
language = "English (US)",
volume = "5",
pages = "292--294",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Cancer and leukemia group b/southwest oncology group trial 80405

T2 - A phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma

AU - Venook, Alan P.

AU - Blanke, Charles

AU - Niedzwiecki, Donna

AU - Lenz, Heinz Josef

AU - Taylor, John R.

AU - Hollis, Donna R.

AU - Sutherland, Susan

AU - Goldberg, Richard M.

PY - 2005

Y1 - 2005

KW - Bevacizumab

KW - Cetuximab

KW - FOLFIRI

KW - FOLFOX

UR - http://www.scopus.com/inward/record.url?scp=33644836082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644836082&partnerID=8YFLogxK

U2 - 10.3816/CCC.2005.n.043

DO - 10.3816/CCC.2005.n.043

M3 - Article

VL - 5

SP - 292

EP - 294

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 4

ER -